Qualgen Recalls Testosterone Pellets Due to Sterility Concerns
Qualgen, LLC is recalling specific lots of Testosterone 37.5 mg pellets nationwide due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (sterility issue) where no specific injuries or illnesses have been reported in the source text, fitting the 'High' severity criteria for theoretical or unreported harm risks.
Plain-English summary
Qualgen, LLC is recalling specific lots of Testosterone 37.5 mg pellets, available in 1, 6, 12, and 30-count vials. The recall is being conducted because of a lack of assurance of sterility for the affected products.
The affected lots are C245 (BUD: 11/28/2018), D005 (BUD: 1/5/2019), D027 (BUD: 1/31/2019), D035 (BUD: 2/9/2019), and D058 (BUD: 3/9/2019). These products were distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot numbers and discontinue use if found. The source text does not provide specific instructions for disposal or return, but users should contact their healthcare provider or the manufacturer for guidance.
The recalled product
- Product
- Testosterone 37.5 mg pellet, 1 count (NDC 69761-137-01), 6 count (NDC 69761-137-06), 12 count (NDC 69761-137-12) and 30 count (NDC 69761-137-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013
- Manufacturer
- Qualgen, LLC
- Category
- Drug — Injectable Steroids
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lots: C245 BUD: 11/28/2018
- D005 BUD: 1/5/2019
- D027 BUD: 1/31/2019
- D035 BUD: 2/9/2019
- D058 BUD: 3/9/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Qualgen, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Qualgen, LLC
See all →- LowCompounded testosterone pellet vials carry incorrect lot numbers from printing issue
FDA (Drugs) · 2025-07-23
- SevereQualgen Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2018-11-14
- HighRecall of Testosterone 12.5mg Pellet due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- SevereQualgen Recalls Estradiol Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-12-02
- LowQualgen Recalls Testosterone Pellets Due to Incorrect Lot and Expiration Dates
FDA (Drugs) · 2018-07-11
- SevereFDA Recalls Testosterone Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-04
- ModerateQualgen Recalls Estradiol Pellets Due to Quality Assurance Deviations
FDA (Drugs) · 2017-06-14
- SevereTestosterone Sterile Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23